![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-3873|16|4|235-248
ISSN: 1871-5303
Source: Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.16, Iss.4, 2017-02, pp. : 235-248
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Interlinking of Hypoxia and Estrogen in Thyroid Cancer Progression
Current Medicinal Chemistry, Vol. 21, Iss. 11, 2014-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Semaphorins and their Receptors in Stem and Cancer Cells
Current Medicinal Chemistry, Vol. 17, Iss. 30, 2010-10 ,pp. :